Nautilus Biotechnology, Inc.
NAUT
$1.03
$0.021.98%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -12.59% | -16.18% | -17.01% | -13.84% | -11.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.06% | -18.54% | -17.97% | -12.40% | -7.92% |
| Operating Income | 16.31% | 18.54% | 17.97% | 12.40% | 7.92% |
| Income Before Tax | 13.95% | 16.86% | 16.64% | 10.53% | 5.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 13.95% | 16.86% | 16.64% | 10.53% | 5.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.95% | 16.86% | 16.64% | 10.53% | 5.68% |
| EBIT | 16.31% | 18.54% | 17.97% | 12.40% | 7.92% |
| EBITDA | 16.04% | 18.53% | 18.05% | 12.43% | 8.00% |
| EPS Basic | 14.43% | 17.31% | 17.19% | 11.15% | 6.27% |
| Normalized Basic EPS | 15.04% | 17.88% | 17.71% | 13.53% | 8.86% |
| EPS Diluted | 14.43% | 17.31% | 17.19% | 11.15% | 6.27% |
| Normalized Diluted EPS | 15.04% | 17.88% | 17.71% | 13.53% | 8.86% |
| Average Basic Shares Outstanding | 0.57% | 0.56% | 0.66% | 0.71% | 0.64% |
| Average Diluted Shares Outstanding | 0.57% | 0.56% | 0.66% | 0.71% | 0.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |